Abstract
The QRS interval of 56 out of 75 (74.7%) HIV-infected, drug-experienced patients (66.7% men) increased during treatment with boosted or unboosted atazanavir by a median 5 ms (interquartile range 0-9; P <0.0001); the PR and the QTc intervals did not change significantly. New asymptomatic bundle branch blocks were observed in four patients; one subject with a baseline first-degree atrioventricular block developed symptomatic bradyarrhythmia while receiving atenolol. The electrocardiographic monitoring of patients treated with atazanavir seems advisable.
Original language | English |
---|---|
Pages (from-to) | 1648-1651 |
Number of pages | 4 |
Journal | AIDS (London, England) |
Volume | 21 |
Issue number | 12 |
DOIs | |
Publication status | Published - Jul 2007 |
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy